UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Platelet antibody identification: toward a solution

Blood, 2016-02, Vol.127 (6), p.665-666

Skogen, Bjørn

2016

Volltextzugriff (PDF)

Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model

Reproductive biology and endocrinology, 2017-04, Vol.15 (1), p.28-28, Article 28

2017

Volltextzugriff (PDF)

A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, a Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention

Thrombosis and haemostasis, 2024-09

2024

Volltextzugriff (PDF)

A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn

Haematologica (Roma), 2008-06, Vol.93 (6), p.870-877

2008

Volltextzugriff (PDF)

An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study

Journal of thrombosis and haemostasis, 2023-04, Vol.21 (4), p.838-849

2023

Volltextzugriff (PDF)

Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities

International journal of women's health, 2017-01, Vol.9, p.223-234

2017

Volltextzugriff (PDF)

Screening for fetal and neonatal alloimmune thrombocytopenia – lessons learned from a Norwegian screening program

Acta obstetricia et gynecologica Scandinavica, 2018-06, Vol.97 (6), p.766-767

2018

Volltextzugriff (PDF)

Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia

Blood advances, 2021-09, Vol.5 (18), p.3552-3562

2021

Volltextzugriff (PDF)

Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia—Antibody specificity analysis using epitope data

Journal of reproductive immunology, 2017-08, Vol.122, p.1-9

2017

Volltextzugriff (PDF)

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

Blood, 2014-01, Vol.123 (4), p.471-480

2014

Volltextzugriff (PDF)

The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data

Blood, 2011-09, Vol.118 (9), p.2638-2639

2011

Volltextzugriff (PDF)

Is it time to implement HPA-1 screening in pregnancy?

Current opinion in hematology, 2009-11, Vol.16 (6), p.497-502

2009

Volltextzugriff (PDF)

Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?

Transfusion and apheresis science, 2008-06, Vol.38 (3), p.183-188

2008

Volltextzugriff (PDF)

Anti-human platelet antigen-1α immunoglobulin G preparation intended to prevent fetal and neonatal alloimmune thrombocytopenia

PloS one, 2016-09

2016

Volltextzugriff (PDF)

Atomic-Level Dissection of the Polyclonal Immune Response to the Human Platelet Alloantigen, HPA-1a (PlA1)

Blood, 2018-11, Vol.132 (Supplement 1), p.1258-1258

2018

Volltextzugriff (PDF)

Maternal anti-platelet [Beta]3 integrins impair angiogenesis and cause intracranial hemorrhage

The Journal of clinical investigation, 2015-04, Vol.125 (4), p.1545

2015

Volltextzugriff (PDF)

Recreation of Fetal Neonatal Alloimmune Thrombocytopenia in CRISPR/Cas9 Gene-Edited Mice Expressing the Human Platelet Alloantigen, HPA-1a

Blood, 2017-12, Vol.130 (Suppl_1), p.764-764

2017

Volltextzugriff (PDF)

Maternal Anti-Platelet β3 Integrin Antibodies Impair Angiogenesis and Cause Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia

Blood, 2014-12, Vol.124 (21), p.2772-2772

2014

Volltextzugriff (PDF)

An Authentic Murine Model of Fetal/Neonatal Alloimmune Thrombocytopenia

Blood, 2019-11, Vol.134 (Supplement_1), p.97-97

2019

Volltextzugriff (PDF)

Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in a Preclinical Model By Monoclonal Anti-HPA-1a Antibody Prophylaxis: Structural and Functional Properties of Antibody Variant Isoforms

Blood, 2021-11, Vol.138 (Supplement 1), p.1011-1011

2021

Volltextzugriff (PDF)

Association Between Maternal Anti-HPA1a Antibodies and Birth Weight of the Newborn

Blood, 2009-11, Vol.114 (22), p.2405-2405

2009

Volltextzugriff (PDF)

Kristian Hannestad

Tidsskrift for den Norske Lægeforening, 2021

2021

Volltextzugriff (PDF)

A combined effect of anti‐HPA‐1a and anti‐HLA Class I in pregnancy?

Transfusion (Philadelphia, Pa.), 2020-09, Vol.60 (9), p.2121-2129

2020

Volltextzugriff (PDF)

Administration of Anti-Platelet Antibodies Prevents the Anti-Platelet Immune Response and Bleeding Complications of Neonatal Immune Thrombocytopenia in a Murine Model

Blood, 2009-11, Vol.114 (22), p.223-223

2009

Volltextzugriff (PDF)

The Development of Severe Anti-HPA 1a-Related Neonatal Alloimmune Thrombocytopenia Is Influenced by the Maternal ABO Type

Blood, 2007-11, Vol.110 (11), p.2093-2093

2007

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaAntigens, Human Platelet - Immunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(57)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Platelet antibody identification: toward a solution

Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model

A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, a Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention

A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn

An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study

Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities

Screening for fetal and neonatal alloimmune thrombocytopenia – lessons learned from a Norwegian screening program

Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia

Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia—Antibody specificity analysis using epitope data

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data

Is it time to implement HPA-1 screening in pregnancy?

Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?

Anti-human platelet antigen-1α immunoglobulin G preparation intended to prevent fetal and neonatal alloimmune thrombocytopenia

Atomic-Level Dissection of the Polyclonal Immune Response to the Human Platelet Alloantigen, HPA-1a (PlA1)

Maternal anti-platelet [Beta]3 integrins impair angiogenesis and cause intracranial hemorrhage

Recreation of Fetal Neonatal Alloimmune Thrombocytopenia in CRISPR/Cas9 Gene-Edited Mice Expressing the Human Platelet Alloantigen, HPA-1a

Maternal Anti-Platelet β3 Integrin Antibodies Impair Angiogenesis and Cause Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia

An Authentic Murine Model of Fetal/Neonatal Alloimmune Thrombocytopenia

Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in a Preclinical Model By Monoclonal Anti-HPA-1a Antibody Prophylaxis: Structural and Functional Properties of Antibody Variant Isoforms

Association Between Maternal Anti-HPA1a Antibodies and Birth Weight of the Newborn

Kristian Hannestad

A combined effect of anti‐HPA‐1a and anti‐HLA Class I in pregnancy?

Administration of Anti-Platelet Antibodies Prevents the Anti-Platelet Immune Response and Bleeding Complications of Neonatal Immune Thrombocytopenia in a Murine Model

The Development of Severe Anti-HPA 1a-Related Neonatal Alloimmune Thrombocytopenia Is Influenced by the Maternal ABO Type

Aktive Filter

Suchergebnisse filtern